Start Date
October 31, 2020
Primary Completion Date
January 1, 2022
Study Completion Date
June 1, 2022
Hydroxychloroquine
Hydroxychloroquine is currently widely used for treatment of autoimmune disease including systemic lupus erythematosus and rheumatoid arthritis, and it has been used to prevent and treat malaria.
Kootenai Health, Coeur d'Alene
Lead Sponsor
Washington State University
OTHER
Kootenai Health
OTHER